Our Vision
To promote and sustain an enabling competition culture through engagement and enforcement that would inspire businesses to be fair, competitive and innovative; enhance consumer welfare; and support economic growth.
What We Do
Latest Updates
- National Conference on Competition Law under Azadi Ka Amrit Mahotsav Invitation
- National Conference on Competition Law under Azadi Ka Amrit Mahotsav Agenda
- List winners of Quiz Competition
- List Winners of Essay Competition
- Call for Papers - 8th National Conference on Economics of Competition Law 2023
- Call for Papers - CCI Journal on Competition Law and Policy
- Resumption of CCI Physical Internship Programme from September 2022
- Call for Papers - CCI Journal on Competition Law and Policy
- Extension of CCI Online Intership Programme - July to August, 2022
- 13th Annual Day CCI Agenda
- Delegation from Bangladesh Competition Commission visited CCI_India on a training/ exposure tour.
- The Final Round of the Moot was judged by Shri Ved Prakash Mishra (Adviser & Head of Legal Division)
- UNCTAD’s eCommerce Week 2022 was recently concluded where a high-level session on Digital platforms, competition & data protection was organised
- 2nd MIT-WPU National Moot Court Competition, Pune
- CCI organized workshop in collaboration with National Law University and Judicial Academy, Guwahati, Assam
- Under Azadi Ka Amrit Mahotsav CCI conducted Eastern Region Workshop on Competition Compliance in Public Procurement
- CCI released Vol. 2 of CCI Journal on Competition Law and Policy.
- CCI conducted a regional workshop on Competition Issues in Mergers and Acquisitions under Azadi ka Amrit Mahotsav at Chennai.
- CCI organised 29th Lecture under SLS delivered by Shri Satish Kumar Gupta, Insolvency Professional on 'Resolution of Essar Steel India Ltd. under IBC - Challenges & Learnings'
- CCI approves acquisition of Corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings (No.2) Limited (“JVCO”) under Section 31(1) of the Competition Act, 2002
- CCI approves proposed transaction involving the sale of the global biosimilars portfolio of Viatris Inc. to Biocon Biologics Limited (Biocon Biologics) and an equity infusion in Biocon Biologics by Biocon and Serum (Proposed Transaction).
- CCI approves acquisition of entire shareholding in Air Asia India by Air India
- CCI approves acquisition of up to 24.98% shareholding of IIFL Wealth Management Limited by BC Asia Investments X Limited
- CCI penalises firms found guilty of bid rigging and cartelization in Indian Railways tenders
- CCI issues cease and desist order against Amateur Baseball Federation of India for abusing its dominant position
- CCI approves acquisition of shareholding in Hitachi Construction Machinery Co., Ltd. by HCJI Holdings G.K., Citrus Investments, HCJ Holdings 2 G.K., Japan Industrial V – GP K.K., and other investors.
- 13th Annual Day CCI Press Release
- CCI approves acquisition of minority stake of BDR Pharmaceuticals International Private Limited (BDR/Target) by Multiples Private Equity Fund III, SRF Transnational Holdings Limited (SRF Transnational), Balkrishna Industries Limited (BIL), Dharmayug Investments Limited (DIL), QRG Investments and Holdings Limited (QRG), Mr. Nishant K. Agarwal and Ms. Mallika Srinivasan (Acquirers)
- CCI approves acquisition of certain compulsorily convertible preference shares of Hero FinCorp Limited (Target) by AHVF II Holdings Singapore II Pte. Ltd. (Acquirer) under Section 31(1) of the Competition Act, 2002.
Launch of Website